Biocon arm gets supplemental USFDA approval for autoimmune disease drug
Yesintek is indicated for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.